Capex / expansionFiled on BSE ·
Anuh Pharma Limited signs Asset Transfer Agreement to acquire Vanquest Pharma facility
What the filing says
- Agreement signed on 16th October 2026 to purchase manufacturing facility from Vanquest Pharma Private Limited
- Purchase includes land, building, plant & machineries for ₹72.90 crore, excluding taxes and fees
- Transaction will increase production capacity by 525 MTPA; not a related party transaction and no shares issued
Original filing
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Anuh Pharma Ltd
Other capex / expansion filings this fortnight
- Capex / expansionIndo Rama Synthetics (India) LtdIndo Rama Synthetics approves ₹200 crore capex for expansion at Butibori plant
- Capex / expansionJuniper GreenJuniper Green Energy commissions 65.40 MW wind capacity at subsidiary project
- Capex / expansionTembo Global Industries LtdTembo Global Industries Limited lists on BSE Main Board and expands defence focus
- Capex / expansionKabra Extrusion Technik LtdKabra Extrusiontechnik Ltd reports Q2 FY27 revenue increase of 64.2% and PAT growth of 1,084.8%
- Capex / expansionAegis LogisticsAegis Logistics commissions specialised LPG Bottling Plant at JNPA on Oct 15, 2026
- Capex / expansionHariom Pipe Industries LtdHariom Pipe Industries subsidiary commissions two 5 MW solar power plants
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.